Skip to main content
. Author manuscript; available in PMC: 2016 Jul 22.
Published in final edited form as: Med Oncol. 2016 Jan 9;33(2):13. doi: 10.1007/s12032-015-0728-2

Figure 1. TFFS for All Patients.

Figure 1

Kaplan-Meier Analysis of Treatment Failure-Free Survival (TFFS) for All 31 Patients Treated with Nab-Paclitaxel for Recurrent or Platinum-Refractory Stage IV Non-Small Cell Lung Cancer (NSCLC)